| Literature DB >> 32611614 |
Samantha M Ervin1, Matthew R Redinbo2,3.
Abstract
The human gut microbiome intimately complements the human genome and gut microbial factors directly influence health and disease. Here we outline how the gut microbiota uniquely contributes to cancer etiology by processing products of human drug and endobiotic metabolism. We formally propose that the reactions performed by the gut microbiota should be classified as "Phase IV xenobiotic and endobiotic metabolism." Finally, we discuss new data on the control of cancer by the inhibition of gut microbial phase IV enzymes responsible for tumor initiation and progression. ©2020 American Association for Cancer Research.Entities:
Year: 2020 PMID: 32611614 DOI: 10.1158/1940-6207.CAPR-20-0155
Source DB: PubMed Journal: Cancer Prev Res (Phila) ISSN: 1940-6215